Alfieri

EDWARDS ANNOUNCES SIX-MONTH DATA CONFIRMING TEER AS SAFE AND EFFECTIVE FOR DMR IN FIRST HEAD-TO-HEAD TRIAL

Retrieved on: 
Saturday, September 17, 2022
Linda, Safety, Edwards Lifesciences, Quality of life, Alfieri, Critical care, U.S. Securities and Exchange Commission, Ventricular remodeling, MitraClip, Significance, CLASP, Drug Quality and Security Act, Annual report, DMR, View, YouTube, PASCAL, NYSE, MD, Quality, CE marking, News, Forward-looking statement, Instagram, Edwards, Security (finance), Transcatheter arterial chemoembolization, Mitral valve, Risk, Securities Exchange Act of 1934, Adrenal insufficiency, Twitter, LinkedIn, Securities Act of 1933, Stroke, Structural heart disease, Randomized controlled trial, Multimedia, University, TCT, Pharmaceutical industry, Medical imaging, Medical device, Patient, Facebook

The study confirms TEER as a safe and effective therapy in patients with degenerative mitral regurgitation (DMR).

Key Points: 
  • The study confirms TEER as a safe and effective therapy in patients with degenerative mitral regurgitation (DMR).
  • The PASCAL system further demonstrated significant and sustained MR 1+ with 83.7 percent of patients at MR 1+ at six months.
  • The CLASP IID trial is a prospective randomized controlled trial comparing the safety and effectiveness of the PASCAL system to the MitraClip system.
  • Edwards, Edwards Lifesciences, the stylized E logo, CLASP, Edwards PASCAL, Edwards PASCAL Precision, PASCAL, and PASCAL Precision are trademarks of Edwards Lifesciences Corporation.

EDWARDS PASCAL PRECISION TRANSCATHETER VALVE REPAIR SYSTEM RECEIVES FDA APPROVAL FOR DEGENERATIVE MITRAL REGURGITATION

Retrieved on: 
Thursday, September 15, 2022
YouTube, Securities Exchange Act of 1934, Adrenal insufficiency, PASCAL, Safety, Twitter, NYSE, Oregon Health & Science University, FDA, CLASP, Drug Quality and Security Act, TVT, Edwards Lifesciences, Division, LinkedIn, CE marking, News, Alfieri, Securities Act of 1933, U.S. Securities and Exchange Commission, Critical care, Patient, Forward-looking statement, History, Medical school, Instagram, Annual report, DMR, Leadership, TCT, Randomized controlled trial, Associate, Security (finance), Multimedia, Oregon Health and Science University Center for Women's Health, School, View, Mitral valve, Pharmaceutical industry, Medical device, Facebook

IRVINE, Calif., Sept. 15, 2022 /PRNewswire/ --Edwards Lifesciences Corporation (NYSE: EW), today announced the company's PASCAL Precision transcathetervalve repair system for transcatheter edge-to-edge repair (TEER) has received FDA approval for the treatment of patients with degenerative mitral regurgitation (DMR).

Key Points: 
  • IRVINE, Calif., Sept. 15, 2022 /PRNewswire/ --Edwards Lifesciences Corporation (NYSE: EW), today announced the company's PASCAL Precision transcathetervalve repair system for transcatheter edge-to-edge repair (TEER) has received FDA approval for the treatment of patients with degenerative mitral regurgitation (DMR).
  • With FDA approval of the PASCAL system, US clinicians now have an additional option for treating patients with severe mitral regurgitation."
  • Transcatheter Edge-to-Edge Repair (TEER) of the mitral valve isused in the treatment of mitral regurgitation.
  • Edwards, Edwards Lifesciences, the stylized E logo, CLASP, Edwards PASCAL, Edwards PASCAL Precision, PASCAL, and PASCAL Precision are trademarks of Edwards Lifesciences Corporation.

Kreps PR Merges with BrandStar

Retrieved on: 
Monday, March 1, 2021
Marketing, Entertainment, Advertising, Communications, TV and Radio, Public relations, Investor relations, Kreps, Coral Gables, Florida, Alfieri, Cities in the United States, Geography of Florida, BrandStar, Kreps PR & Marketing

View the full release here: https://www.businesswire.com/news/home/20210301005602/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210301005602/en/
    Israel Kreps of Kreps PR merges with Mark Alfieri of BrandStar (Photo: Business Wire)
    Founded by Mark Alfieri, BrandStars award-winning TV programming airs on Lifetime Television, Bloomberg, FOX Business, and numerous syndicated outlets, and includes shows such as Designing Spaces, currently in its 15th year, The Balancing Act, in its 20th year, Inside the Blueprint and Access Health.
  • Bringing a team with the capabilities and bandwidth of the Kreps organization into the BrandStar ecosystem provides us an additional value proposition that is simply unmatched in today's environment, said Mark Alfieri, Founder & CEO of BrandStar.
  • Kreps PR will continue at its current location in Coral Gables, Fla., at 220 Alhambra Circle.
  • Kreps PR & Marketing, with a presence in Miami and New York City, is one of the industrys most trusted agencies.

BrandStar Seeks to Replace Late Host R. Lee Ermey for TV Series Military Makeover

Retrieved on: 
Wednesday, May 9, 2018
R. Lee Ermey, United States Marine Corps, Gunnery sergeant, Alfieri, Military personnel, Military

DEERFIELD BEACH, Fla., May 9, 2018 /PRNewswire/ -- BrandStar, producers of home improvement series Military Makeover, which airs on Lifetime TV, is seeking to cast a replacement for longtime host R. Lee Ermey, the Golden Globe-nominated actor who passed away last month.

Key Points: 
  • DEERFIELD BEACH, Fla., May 9, 2018 /PRNewswire/ -- BrandStar, producers of home improvement series Military Makeover, which airs on Lifetime TV, is seeking to cast a replacement for longtime host R. Lee Ermey, the Golden Globe-nominated actor who passed away last month.
  • Ermey, known as The Gunny, proudly served as the host for Military Makeover for more than four years, helping rebuild the lives of his fellow veterans and facilitate the renovations of their homes, along with the series' partners.
  • "We were blessed to have had the opportunity to work with R. Lee Ermey these past four years," said Mark Alfieri, Founder and CEO of BrandStar.
  • Military Makeover offers hope and a helping hand to members of our military and their loved ones.